BRTX
BioRestorative Therapies, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.69
+1.32%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+594.4%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Oct 20, 2025 | ALSTODT LANCE · director, 10 percent owner, officer: President, CEO, COB | A-Award | 11,719 | $2.75 |
| Oct 20, 2025 | Silva Francisco · director, officer: VP of Research and Development | A-Award | 11,719 | $1.60 |
| Oct 20, 2025 | ALSTODT LANCE · director, 10 percent owner, officer: President, CEO, COB | A-Award | 15,625 | $1.60 |
| Feb 19, 2025 | Kukekov Nickolay V. · director | A-Award | 52,632 | $2.46 |
| Feb 19, 2025 | Kristal Robert Eugene · officer: Chief Financial Officer | A-Award | 166,492 | $2.46 |
| Feb 19, 2025 | Williams Patrick F. · director | A-Award | 52,632 | $2.46 |
| Feb 19, 2025 | ALSTODT LANCE · director, officer: President, CEO, COB | A-Award | 791,885 | $2.46 |
| Feb 19, 2025 | Silva Francisco · director, officer: VP of Research and Development | A-Award | 768,979 | $2.46 |
| Feb 19, 2025 | Rosa David A · director | A-Award | 52,632 | $2.46 |
| Nov 5, 2024 | Broadrick Dale · 10 percent owner | Sale | 1,112 | $1.58 |
| Apr 10, 2024 | Silva Francisco · director, officer: VP of Research and Development | Purchase | 6,600 | $1.25 |
| Apr 10, 2024 | Silva Francisco · director, officer: VP of Research and Development | Purchase | 1,232 | $1.17 |
| Apr 10, 2024 | Silva Francisco · director, officer: VP of Research and Development | Purchase | 476 | $1.13 |
| Mar 20, 2024 | ALSTODT LANCE · director, officer: President, CEO, COB | F-InKind | 17,633 | $1.39 |
| Mar 20, 2024 | Silva Francisco · director, officer: VP of Research and Development | F-InKind | 17,193 | $1.39 |
| Feb 15, 2024 | ALSTODT LANCE · director, 10 percent owner, officer: President, CEO, COB | A-Award | 438,596 | $1.45 |
| Feb 15, 2024 | Kristal Robert Eugene · officer: Chief Financial Officer | A-Award | 263,158 | $1.45 |
| Feb 15, 2024 | Williams Patrick F. · director | A-Award | 79,646 | $1.45 |
| Feb 15, 2024 | Silva Francisco · director, 10 percent owner, officer: VP of Research and Development | A-Award | 394,737 | $1.45 |
| Feb 15, 2024 | Rosa David A · director | A-Award | 79,646 | $1.45 |
| Feb 15, 2024 | Paccasassi Robert · officer: VP, QA and Reg Compliance | A-Award | 219,298 | $1.45 |
| Feb 15, 2024 | Kukekov Nickolay V. · director | A-Award | 79,646 | $1.45 |
| Feb 12, 2024 | Broadrick Dale · 10 percent owner | Purchase | 73,959 | $1.25 |
| Feb 12, 2024 | Broadrick Dale · 10 percent owner | Purchase | 86,041 | $1.32 |
| Feb 9, 2024 | Broadrick Dale · 10 percent owner | Purchase | 83,626 | $1.34 |
| Feb 9, 2024 | Broadrick Dale · 10 percent owner | Purchase | 36,374 | $1.38 |
| Dec 5, 2023 | Broadrick Dale · 10 percent owner | Sale | 250 | $1.88 |
| Dec 1, 2023 | Broadrick Dale · 10 percent owner | Sale | 278 | $1.89 |
| Sep 18, 2023 | ALSTODT LANCE · director, 10 percent owner, officer: President, CEO, COB | Purchase | 2,200 | $1.70 |
| Sep 18, 2023 | Broadrick Dale · 10 percent owner | Purchase | 10,000 | $1.66 |
Institutional positioning
13F filings over the trailing two quarters
New 13Increased 8Reduced 2Sold out 0
| Filer | Action | Shares | Filed |
|---|---|---|---|
| JANE STREET GROUP, LLC | New Position | 803,513 | Aug 14, 2026 |
| HRT FINANCIAL LP | New Position | 710,590 | Aug 14, 2026 |
| XTX Topco Ltd | New Position | 286,504 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 273,304 | Sep 2, 2026 |
| CITADEL ADVISORS LLC | Increased | 238,606 | May 15, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 223,083 | May 15, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Increased | 181,300 | Aug 13, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Reduced | 152,417 | Aug 12, 2026 |
| UBS GROUP AG | New Position | 99,832 | May 5, 2026 |
| CITIGROUP INC | New Position | 63,724 | Aug 3, 2026 |
| WEALTH ALLIANCE | Unchanged | 40,000 | May 14, 2026 |
| WEALTH ALLIANCE, LLC | Unchanged | 40,000 | Aug 11, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 39,452 | May 8, 2026 |
| STATE STREET CORP | Unchanged | 32,459 | Aug 7, 2026 |
| STATE STREET CORP | Unchanged | 32,459 | May 15, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Oct 20, 2025